BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25011268)

  • 1. [Role of ERK/FoxO3a signal axis in inhibitory effect of vitexin 1 (VB-1) in HepG2 cell proliferation].
    Zheng XX; Zhang RS; Zhou YJ; Wang JG
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1276-9. PubMed ID: 25011268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
    Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
    Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
    Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
    Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
    J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
    Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
    Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism study on anti-proliferative effects of curcumol in human hepatocarcinoma HepG2 cells].
    Huang LZ; Wang J; Lu FT; Yang FC; Chen X; Hong X; Jiang XS
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1812-5. PubMed ID: 24010301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.
    He L; Yang X; Cao X; Liu F; Quan M; Cao J
    Oncol Rep; 2013 Jan; 29(1):103-8. PubMed ID: 23064420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
    J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effect of Eucalyptus citriodora resin on human hepatoma HepG2 cells.
    Shen KH; Chen ZT; Duh PD
    Am J Chin Med; 2012; 40(2):399-413. PubMed ID: 22419432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
    Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between inhibitory effect of Manumycin on human hepatoma cancer cell HepG2 and Ras signal transduction pathway].
    Zhou JM; Pan QC; Yang XP; Liu ZC; Liao DF; Fu LW; Liang YJ
    Ai Zheng; 2002 Apr; 21(4):364-8. PubMed ID: 12452012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of angiotensin II (Ang II) on the proliferation of human hepatoma cell line HepG2 cells].
    Qi R; Lei CG; Bai YX; Xing X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):601-606. PubMed ID: 30317792
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells.
    Tang ZH; Li T; Chang LL; Zhu H; Tong YG; Chen XP; Wang YT; Lu JJ
    J Agric Food Chem; 2014 Dec; 62(49):11910-6. PubMed ID: 25403108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of magnesium cantharidate on human hepatoma SMMC-7721 cell proliferation by blocking MAPK signaling pathway].
    Liu Y; Li X; Zou Q; Liu L; Zhu X; Jia Q; Wang L; Yan R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):347-351. PubMed ID: 28274314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.